Thoracic and GI Oncology Conference (Attendee Information)

At the conclusion of this activity, the participants should be better able to:

Thoracic

1. Name the biomarkers used in non-small cell lung cancer.
2. State the changes in treatment guidelines for lung cancers.
3. Explain the controversies of radiation for small cell lung cancer treatment.
4. Interpret the Commission on Cancer operative standards regarding nodal sampling for lung cancer.

GI

1. Define the use of artificial intelligence (AI) in pathology.
2. Discuss the controversies and challenges in the management of esophageal and gastroesophageal junction cancers.
3. Identify the challenges in the treatment of early-onset GI cancers.
4. Recognize the indication and benefits of hepatic artery pump for liver-directed therapy.
5. Articulate the association between obesity and cancer survival.
6. Outline the barriers to colon cancer screening.

In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Nebraska Medicine. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

FULL CONFERENCE

The University of Nebraska Medical Center designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

THORACIC

The University of Nebraska Medical Center designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

GI

The University of Nebraska Medical Center designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

FULL CONFERENCE

12.75 Contact Hours Awarded
Nebraska Medicine is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

THORACIC

6.0 Contact Hours Awarded
Nebraska Medicine is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

GI

6.75 Contact Hours Awarded
Nebraska Medicine is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Read the UNMC CCE Disclosure Declaration Policy 

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.

FACULTY

The following have disclosed relevant financial relationships:

• Allison Cushman-Vokoun, MD PhD
  Speaker: Academy for Continued Health Care Learning, Thermo Fisher Scientific Inc.
• Apar Kishor Ganti, MD
  Consultant: AstraZeneca, Cardinal Health, Jazz Pharmaceuticals
  Research Support: Chimerix; IOVANCE Biotherapeutics, Inc.; Merck & Co., Inc.; Mirati Therapeutics; Poseida, Inc.

• Joseph J. McBride, MD
  Consultant: Integer Holdings Corporation
• Terence T. Sio, MD, MS
  Advisory Board: Catalyst Pharmaceuticals, Inc.; Galera Therapeutics, Inc.
• Benjamin J. Swanson, MD, PhD
• Consultant, Stock Ownership: Cogen Bioscience, Inc.

The following have nothing to disclose:

• Lauren B. Beach, PhD
• David Berkheim, MD
• Matt DeVries, MD
• Jean Grem, MD
• Haejin In, MD, MPH, MBA, FACS, FSSO
• Mridula Krishnan, MBBS
• Rudy P. Lackner, MD, FACS, FCCP*
• Jennifer A. Leinicke, MD, MPHS, FACS, FASCRS
• Erik E. Lewis, MD
• Quan P. Ly, MD, FACS*
• Corrigan McBride, MD, MBA, FACS, FASMBS, DABS, DABS-FPDMBS, DABOM
• Kate-Lynn E. Muir, DO
• James C. Padussis, MD
• Grace Saunders, MS, LCGC
• Laura Tenner, MD, MPH
• Weining (Ken) Zhen, MD, FACR, FASTRO

PLANNING COMMITTEE 

The following have nothing to disclose:

• Missy Edwards

• Julie Huglin
• Jacqueline Siebels, BSN, RN, NPD-BC

*Faculty and planning committee member

The following materials (in PDF) are available for download until Nov. 21, 2024. No part of these materials may be reproduced without prior written permission.

Thursday, Oct. 31 - Thoracic Session

• The Role of Radon in Lung Cancer
  David B. Berkheim, MD
• Interstitial Lung Disease (ILD) in Thoracic Oncology
  Case Study
  Matt DeVries, MD
• Rapid Molecular Biomarker Testing at Primary Diagnosis: We Can Do a Lot With a Little
  Allison Cushman-Vokoun, MD, PhD
• Choosing Between Surgery and Stereotactic Body Radiation for Patients with Early-Stage Non-Small Cell Lung Cancer
  Terence T. Sio, MD, MS
• Targeted Therapy for Early-Stage Non-Small Cell Lung Cancer
  Kate-Lynn E. Muir, DO
• The Current Status of Neo-Adjuvant Therapy in Non-Small Cell Lung Cancer
  Apar Kishor Ganti, MD
• The Role and Controversies for Radiation Therapy in Small Cell Lung Cancer
  Weining (Ken) Zhen, MD, FACR, FASTRO
• Operative Standards for Lung Cancer/Nodal Sampling Versus Dissection: What’s the Correct Choice
  Rudy P. Lackner, MD, FACS, FCCP

Friday, Nov. 1 - GI Session 

• The Use of Artificial Intelligence (AI) in Pathology
  Benjamin J. Swanson, MD, PhD
• Controversies in the Management of Gastroesophageal Junction (GEJ) Cancers
  Haejin In, MD, MPH, MBA, FACS, FSSO
• Early-Onset Gastrointestinal (GI) Cancers
  Laura Tenner, MD, MPH
• Hepatic Artery Pump for Liver-Directed Therapy
  James C. Padussis, MD
• Vascular Access Management and Complications
  Joseph J. McBride, MD
• Sex, Sexual Orientation, and Gender Identity (SSOGI) Data Collection
  Lauren B. Beach, PhD
• Approach to Cancer Screening in LGBTQIA+ Population
  Grace Saunders, MS, LCGC
• Updates in Anal Cancer Management
  Jennifer A. Leinicke, MD, MPHS, FACS, FASCRS
• Precision-Guided Management of GI Malignancies
  Mridula Krishnan, MBBS
• Esophagogastrectomy in Octogenarian
  Erik E. Lewis, MD
• Update in the Management of Small Bowel Neuroendocrine Tumors
  Jean Grem, MD
• Obesity and Cancer Survival
  Corrigan McBride, MD, MBA, FACS, FASMBS, DABS, DABS-FPDMBS, DABOM
• Community Engagement Activities
  Quan P. Ly, MD, FACS